Exploring the results of ACE’s AI and Arthritis National Survey

Artificial Intelligence (AI) is changing the way health care is delivered across the country. From helping diagnose disease earlier to predicting arthritis flare-ups and supporting treatment choices, AI has the potential to transform how patients experience care. But what do Canadians living with arthritis think about this technology?In this new Arthritis at Home episode, Kelly Lendvoy, ACE’s VP of Communications and Public Affairs, speaks with Ellen Wang, project manager at Arthritis Consumer Experts (ACE), about the key takeaways from the AI and Arthritis National Survey findings. What you’ll learn in this episode:Patient voices on AI: How people with arthritis feel about AI in their care journey.Trust and oversight: Why patients want doctors to remain central to decision-making, even when AI is used.Concerns and opportunities: What patients see as the risks (privacy, fairness, loss of human connection) and potential benefits (shorter wait times, earlier diagnosis, better treatment matches).Equity matters: Perspectives from Indigenous, Black, racialized, rural, and lower-income respondents, highlighting the importance of inclusive AI design.Additional learning resourcesRead the complete Survey findings in the newest issue of JointHealth™ insight Learn more about AI Scribing in rheumatology clinics